Ghent University Academic Bibliography

Advanced

Epstein-Barr virus related lymphoma in inflammatory bowel disease

Stephanie Van Biervliet UGent, SASKIA VANDE VELDE UGent, Ruth De Bruyne UGent, Danny De Looze UGent, MARTINE DE VOS UGent and Myriam Van Winckel UGent (2008) ACTA GASTRO-ENTEROLOGICA BELGICA. 71(1). p.33-35
abstract
Epstein-Barr virus (EBV) induced lymphoproliferative disease is a well-known, feared complication of EBV primo-infection in children treated with immunomodulators or immunosuppressive drugs, eg after transplantation. As the incidence of inflammatory bowel disease (IBD) in young children is rising, more young EBV naive patients are treated with immunomodulatory agents. It is not yet clear whether these patients carry the same risk as transplanted patients to develop lymphoproliferative disease and if so, whether their evolution is comparable. We present the history of a young patient with Crohn's disease who developed an EBV related lymphoma shortly after the primo-infection while being treated with azathioprine. This case argues for a rigorous follow up of young IBD patients treated with immune suppressive drugs, also regarding EBV status.
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
keyword
6-MERCAPTOPURINE, RISK, AZATHIOPRINE, CROHNS-DISEASE, IMMUNOSUPPRESSIVE THERAPY
journal title
ACTA GASTRO-ENTEROLOGICA BELGICA
Acta Gastro-Enterol. Belg.
volume
71
issue
1
pages
33 - 35
Web of Science type
Article
Web of Science id
000256170300008
JCR category
GASTROENTEROLOGY & HEPATOLOGY
JCR impact factor
0.832 (2008)
JCR rank
51/55 (2008)
JCR quartile
4 (2008)
ISSN
0001-5644
language
English
UGent publication?
yes
classification
A1
id
427016
handle
http://hdl.handle.net/1854/LU-427016
date created
2008-07-10 14:55:00
date last changed
2011-02-24 10:50:50
@article{427016,
  abstract     = {Epstein-Barr virus (EBV) induced lymphoproliferative disease is a well-known, feared complication of EBV primo-infection in children treated with immunomodulators or immunosuppressive drugs, eg after transplantation. As the incidence of inflammatory bowel disease (IBD) in young children is rising, more young EBV naive patients are treated with immunomodulatory agents. It is not yet clear whether these patients carry the same risk as transplanted patients to develop lymphoproliferative disease and if so, whether their evolution is comparable. We present the history of a young patient with Crohn's disease who developed an EBV related lymphoma shortly after the primo-infection while being treated with azathioprine. This case argues for a rigorous follow up of young IBD patients treated with immune suppressive drugs, also regarding EBV status.},
  author       = {Van Biervliet, Stephanie and VANDE VELDE, SASKIA and De Bruyne, Ruth and De Looze, Danny and DE VOS, MARTINE and Van Winckel, Myriam},
  issn         = {0001-5644},
  journal      = {ACTA GASTRO-ENTEROLOGICA BELGICA},
  keyword      = {6-MERCAPTOPURINE,RISK,AZATHIOPRINE,CROHNS-DISEASE,IMMUNOSUPPRESSIVE THERAPY},
  language     = {eng},
  number       = {1},
  pages        = {33--35},
  title        = {Epstein-Barr virus related lymphoma in inflammatory bowel disease},
  volume       = {71},
  year         = {2008},
}

Chicago
Van Biervliet, Stephanie, Saskia Vande Velde, Ruth De Bruyne, Danny De Looze, MARTINE DE VOS, and Myriam Van Winckel. 2008. “Epstein-Barr Virus Related Lymphoma in Inflammatory Bowel Disease.” Acta Gastro-enterologica Belgica 71 (1): 33–35.
APA
Van Biervliet, S., Vande Velde, S., De Bruyne, R., De Looze, D., DE VOS, M., & Van Winckel, M. (2008). Epstein-Barr virus related lymphoma in inflammatory bowel disease. ACTA GASTRO-ENTEROLOGICA BELGICA, 71(1), 33–35.
Vancouver
1.
Van Biervliet S, Vande Velde S, De Bruyne R, De Looze D, DE VOS M, Van Winckel M. Epstein-Barr virus related lymphoma in inflammatory bowel disease. ACTA GASTRO-ENTEROLOGICA BELGICA. 2008;71(1):33–5.
MLA
Van Biervliet, Stephanie, Saskia Vande Velde, Ruth De Bruyne, et al. “Epstein-Barr Virus Related Lymphoma in Inflammatory Bowel Disease.” ACTA GASTRO-ENTEROLOGICA BELGICA 71.1 (2008): 33–35. Print.